Ensign Group (NASDAQ:ENSG) Stock

ENSIGN GROUP INC/THE

Ensign Group

Ensign Group Inc provides post-acute healthcare services in the United States. Its regional subsidiaries oversee skilled nursing, assisted living, home health and hospice, mobile ancillary, and urgent care operations. Medicare and Medicaid programs contribute majority of revenue received for Ensign's services. The firm operates through two segments, Skilled services, and Standard Bearer. The skilled services segment includes the operation of skilled nursing facilities and rehabilitation therapy services. The Standard Bearer segment comprises of properties owned by the company through its captive REIT and leased to skilled nursing and assisted living operations. The majority of the revenue is generated from the skilled services segment.

Ensign Group Inc

Macquarie analyst Tao Qiu maintains Ensign Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENSG#NASDAQ">ENSG</a>) with a Outperform and lowers the price target from $159 to $156.

News

Price Target

Analyst Ratings

ENSG

Macquarie Maintains Outperform on Ensign Group, Lowers Price Target to $156

Ensign Group Acquires 117-Bed Marianwood Facility In Washington As Part Of Broader 8-Facility Deal

Ensign Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENSG#NASDAQ">ENSG</a>) raises FY2025 GAAP EPS guidance from $6.16-$6.34 to $6.22-$6.38 vs $5.99 analyst estimate. Raises FY2025 sales outlook from $4.83 billion-$4.91 billion to $4.89 billion-$4.94 billion vs $4.87 billion estimate.

Guidance

Ensign Group Raises FY2025 GAAP EPS Guidance from $6.16-$6.34 to $6.22-$6.38 vs $5.99 Est; Raises FY2025 Sales Guidance from $4.83B-$4.91B to $4.89B-$4.94B vs $4.87B Est

Ensign Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENSG#NASDAQ">ENSG</a>) reported quarterly earnings of $1.52 per share which beat the analyst consensus estimate of $1.49 by 2.01 percent. This is a 16.92 percent increase over earnings of $1.30 per share from the same period last year. The company reported quarterly sales of $1.17 billion which met the analyst consensus estimate. This is a 16.14 percent increase over sales of $1.01 billion the same period last year.

Earnings

Earnings Beats

Ensign Group Q1 Adj. EPS $1.52 Beats $1.49 Estimate, Sales $1.17B Inline

ACGL

AEYE

AMSF

APAM

ARCB

ARCC

ASTE

ASTL

ATRC

BBIO

BBVA

BGFV

BKNG

BRSP

CECO

CHCT

CLVT

CSGP

CVLT

DHIL

ENVA

ESRT

ETWO

EXLS

FELE

FFIC

FIBK

FICO

FOUR

FRSH

FRST

FSLR

FYBR

HLMN

HOUS

HRZN

HSBC

HURN

ILPT

INCY

INTZ

JAKK

JBGS

JBLU

KNSA

LFUS

LGIH

Laboratory Corporation Of America Holdings

LOGI

LXFR

Earnings Scheduled For April 29, 2025

Ensign Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENSG#NASDAQ">ENSG</a>) is set to give its latest quarterly earnings report on Tuesday, 2025-04-29. Here's what investors need to know before the announcement.
Analysts estimate that Ensign Group will report an earnings per share (EPS) of $1.48. 
Investors in Ensign Group are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
<h3>Past Earnings Performance</h3>
Last quarter the company beat EPS by $0.01, which was followed by a 8.7% drop in the share price the next day.
Here's a look at Ensign Group's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.48</td>
<td>1.38</td>
<td>1.30</td>
<td>1.28</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.49</td>
<td>1.39</td>
<td>1.32</td>
<td>1.30</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-9.0%</td>
<td>3.0%</td>
<td>5.0%</td>
<td>-2.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1745863387_0.png" alt="eps graph" />
<h3>Ensign Group Share Price Analysis</h3>
Shares of Ensign Group were trading at $126.04 as of April 25. Over the last 52-week period, shares are up 6.4%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<h3>Analyst Views on Ensign Group</h3>
For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Ensign Group.
Analysts have provided Ensign Group with 3 ratings, resulting in a consensus rating of Outperform. The average one-year price target stands at $160.33, suggesting a potential 27.21% upside.
<h3>Peer Ratings Comparison</h3>
The analysis below examines the analyst ratings and average 1-year price targets of Universal Health Services, Encompass Health and Tenet Healthcare, three significant industry players, providing valuable insights into their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Neutral trajectory for Universal Health Services, with an average 1-year price target of $219.86, suggesting a potential 74.44% upside.</li>
<li>Analysts currently favor an Outperform trajectory for Encompass Health, with an average 1-year price target of $122.71, suggesting a potential 2.64% downside.</li>
<li>Analysts currently favor an Outperform trajectory for Tenet Healthcare, with an average 1-year price target of $161.0, suggesting a potential 27.74% upside.</li>
</ul>
<h3>Snapshot: Peer Analysis</h3>
The peer analysis summary outlines pivotal metrics for Universal Health Services, Encompass Health and Tenet Healthcare, demonstrating their respective standings within the industry and offering valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Ensign Group</td>
<td>Outperform</td>
<td>15.49%</td>
<td>$178.91M</td>
<td>4.45%</td>
</tr>
<tr>
<td>Universal Health Services</td>
<td>Neutral</td>
<td>11.08%</td>
<td>$3.71B</td>
<td>5.01%</td>
</tr>
<tr>
<td>Encompass Health</td>
<td>Outperform</td>
<td>3.59%</td>
<td>$585.90M</td>
<td>7.17%</td>
</tr>
<tr>
<td>Tenet Healthcare</td>
<td>Outperform</td>
<td>-5.71%</td>
<td>$4.14B</td>
<td>7.95%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Ensign Group ranks highest in Revenue Growth among its peers. It also leads in Gross Profit margin. However, it has the lowest Return on Equity. Overall, Ensign Group is positioned favorably compared to its peers in terms of financial performance.
<h3>Discovering Ensign Group: A Closer Look</h3>
Ensign Group Inc provides post-acute healthcare services in the United States. Its regional subsidiaries oversee skilled nursing, assisted living, home health and hospice, mobile ancillary, and urgent care operations. Medicare and Medicaid programs contribute majority of revenue received for Ensign's services. The firm operates through two segments, Skilled services, and Standard Bearer. The skilled services segment includes the operation of skilled nursing facilities and rehabilitation therapy services. The Standard Bearer segment comprises of properties owned by the company through its captive REIT and leased to skilled nursing and assisted living operations. The majority of the revenue is generated from the skilled services segment.
<h3>Unraveling the Financial Story of Ensign Group</h3>
Market Capitalization Analysis: Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.
Revenue Growth: Ensign Group displayed positive results in 3 months. As of 31 December, 2024, the company achieved a solid revenue growth rate of approximately 15.49%. This indicates a notable increase in the company's top-line earnings. When compared to others in the Health Care sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: Ensign Group's net margin is impressive, surpassing industry averages. With a net margin of 7.04%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Ensign Group's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 4.45%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Ensign Group's ROA excels beyond industry benchmarks, reaching 1.71%. This signifies efficient management of assets and strong financial health.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 1.07.
<a href="https://www.benzinga.com/quote/ENSG/earnings">To track all earnings releases for Ensign Group visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Ensign Group's Earnings Outlook

Ensign Group's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ENSG#NYSE">ENSG</a>) short percent of float has risen 7.09% since its last report. The company recently reported that it has 2.68 million shares sold short, which is 6.95% of all regular shares that are available for trading. Based on its trading volume, it would take traders 5.73 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Ensign Group Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1745506854_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Ensign Group has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Ensign Group's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Ensign Group's peer group average for short interest as a percentage of float is 4.80%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

How Do Investors Really Feel About Ensign Group?

Ensign Group Adds Five Facilities Across California And Washington, Grows Portfolio To 343 Operations

WIIM

UHAL

Shares of hospital an healthcare stocks are trading lower amid concerns over Medicaid an Medicare cuts. Additionally, President Trump recently signed an executive order on healthcare price transparency.

On February 12, Suzanne Snapper, CFO at Ensign Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENSG#NASDAQ">ENSG</a>) executed a significant insider buy, as disclosed in the latest SEC filing.
What Happened: A Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0001125376/000112537625000034//Archives/edgar/data/1125376/000112537625000034/0001125376-25-000034-index.htm">U.S. Securities and Exchange Commission</a> on Wednesday unveiled that Snapper made a notable purchase of 12,252 shares of Ensign Group, valuing at $1,583,325.
The latest update on Thursday morning shows Ensign Group shares up by 0.7%, trading at $127.0.
<h3>Get to Know Ensign Group Better</h3>
Ensign Group Inc provides post-acute healthcare services in the United States. Its regional subsidiaries oversee skilled nursing, assisted living, home health and hospice, mobile ancillary, and urgent care operations. Medicare and Medicaid programs contribute a majority of revenue received for Ensign's services. The firm operates through two segments, Skilled services, and Standard Bearer. The skilled services segment includes the operation of skilled nursing facilities and rehabilitation therapy services. The Standard Bearer segment comprises of properties owned by the company through its captive REIT and leased to skilled nursing and assisted living operations. The majority of the revenue is generated from the skilled services segment.
<h3>Ensign Group's Financial Performance</h3>
Revenue Growth: Ensign Group's revenue growth over a period of 3 months has been noteworthy. As of 30 September, 2024, the company achieved a revenue growth rate of approximately 14.99%. This indicates a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Health Care sector.
Profitability Metrics:
<ul>
<li>
Gross Margin: The company shows a low gross margin of 15.44%, suggesting potential challenges in cost control and profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): Ensign Group's EPS lags behind the industry average, indicating concerns and potential challenges with a current EPS of 1.38.
</li>
</ul>
Debt Management: Ensign Group's debt-to-equity ratio is below the industry average at 1.15, reflecting a lower dependency on debt financing and a more conservative financial approach.
Valuation Analysis:
<ul>
<li>
Price to Earnings (P/E) Ratio: Ensign Group's stock is currently priced at a premium level, as reflected in the higher-than-average P/E ratio of 24.63.
</li>
<li>
Price to Sales (P/S) Ratio: A higher-than-average P/S ratio of 1.72 suggests overvaluation in the eyes of investors, considering sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): Boasting an EV/EBITDA ratio of 18.17, Ensign Group demonstrates a robust market valuation, outperforming industry benchmarks.
</li>
</ul>
Market Capitalization Highlights: Above the industry average, the company's market capitalization signifies a significant scale, indicating strong confidence and market prominence.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>The Relevance of Insider Transactions</h3>
While insider transactions provide valuable information, they should be part of a broader analysis in making investment decisions.
When discussing legal matters, the term "insider" refers to any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, as stipulated in Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and significant hedge funds. Such insiders are required to report their transactions through a Form 4 filing, which must be completed within two business days of the transaction.
A new purchase by a company insider is a indication that they anticipate the stock will rise.
On the other hand, insider sells may not necessarily indicate a bearish view and can be motivated by various factors.
<h3>The Insider's Guide to Important Transaction Codes</h3>
When it comes to transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> tend to focus on those in the open market, detailed in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S indicates a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001125376">Check Out The Full List Of Ensign Group's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;utm_source=benzinga-insights">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insider Trades

Eye On Growth: Suzanne Snapper Adds $1.58M Of Ensign Group Stock To Portfolio

A new SEC filing reveals that Barry Port, Chief Executive Officer at Ensign Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENSG#NASDAQ">ENSG</a>), made a notable insider purchase on February 12,.
What Happened: Port's recent move, as outlined in a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0001125376/000112537625000036//Archives/edgar/data/1125376/000112537625000036/0001125376-25-000036-index.htm">U.S. Securities and Exchange Commission</a> on Wednesday, involves purchasing 14,154 shares of Ensign Group. The total transaction value is $1,829,121.
In the Thursday's morning session, Ensign Group's shares are currently trading at $127.22, experiencing a up of 0.88%.
<h3>Discovering Ensign Group: A Closer Look</h3>
Ensign Group Inc provides post-acute healthcare services in the United States. Its regional subsidiaries oversee skilled nursing, assisted living, home health and hospice, mobile ancillary, and urgent care operations. Medicare and Medicaid programs contribute a majority of revenue received for Ensign's services. The firm operates through two segments, Skilled services, and Standard Bearer. The skilled services segment includes the operation of skilled nursing facilities and rehabilitation therapy services. The Standard Bearer segment comprises of properties owned by the company through its captive REIT and leased to skilled nursing and assisted living operations. The majority of the revenue is generated from the skilled services segment.
<h3>Breaking Down Ensign Group's Financial Performance</h3>
Revenue Growth: Over the 3 months period, Ensign Group showcased positive performance, achieving a revenue growth rate of 14.99% as of 30 September, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Health Care sector.
Key Profitability Indicators:
<ul>
<li>
Gross Margin: With a low gross margin of 15.44%, the company exhibits below-average profitability, signaling potential struggles in cost efficiency compared to its industry peers.
</li>
<li>
Earnings per Share (EPS): Ensign Group's EPS is below the industry average. The company faced challenges with a current EPS of 1.38. This suggests a potential decline in earnings.
</li>
</ul>
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 1.15.
Market Valuation:
<ul>
<li>
Price to Earnings (P/E) Ratio: Ensign Group's stock is currently priced at a premium level, as reflected in the higher-than-average P/E ratio of 24.63.
</li>
<li>
Price to Sales (P/S) Ratio: With a relatively high Price to Sales ratio of 1.72 as compared to the industry average, the stock might be considered overvalued based on sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): With an impressive EV/EBITDA ratio of 18.17, Ensign Group demonstrates exemplary market valuation, surpassing industry averages.
</li>
</ul>
Market Capitalization Analysis: Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>The Impact of Insider Transactions on Investments</h3>
Insider transactions are not the sole determinant of investment choices, but they are a factor worth considering.
In legal terms, an "insider" refers to any officer, director, or beneficial owner of more than ten percent of a company's equity securities registered under Section 12 of the Securities Exchange Act of 1934. This can include executives in the c-suite and large hedge funds. These insiders are required to let the public know of their transactions via a Form 4 filing, which must be filed within two business days of the transaction.
When a company insider makes a new purchase, that is an indication that they expect the stock to rise.
Insider sells, on the other hand, can be made for a variety of reasons, and may not necessarily mean that the seller thinks the stock will go down. 
<h3>Deciphering Transaction Codes in Insider Filings</h3>
When it comes to transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> tend to focus on those in the open market, detailed in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S indicates a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001125376">Check Out The Full List Of Ensign Group's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;utm_source=benzinga-insights">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Barry Port Takes a Bullish Stance: Acquires $1.83M In Ensign Group Stock

On February 12, Christopher Christensen, Executive Chairman at Ensign Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENSG#NASDAQ">ENSG</a>) executed a significant insider buy, as disclosed in the latest SEC filing.
What Happened: Christensen made a significant move by purchasing 5,023 shares of Ensign Group as reported in a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0001125376/000112537625000038//Archives/edgar/data/1125376/000112537625000038/0001125376-25-000038-index.htm">U.S. Securities and Exchange Commission</a>. The transaction's total worth stands at $649,122.
At Thursday morning, Ensign Group shares are up by 0.88%, trading at $127.22.
<h3>Unveiling the Story Behind Ensign Group</h3>
Ensign Group Inc provides post-acute healthcare services in the United States. Its regional subsidiaries oversee skilled nursing, assisted living, home health and hospice, mobile ancillary, and urgent care operations. Medicare and Medicaid programs contribute a majority of revenue received for Ensign's services. The firm operates through two segments, Skilled services, and Standard Bearer. The skilled services segment includes the operation of skilled nursing facilities and rehabilitation therapy services. The Standard Bearer segment comprises of properties owned by the company through its captive REIT and leased to skilled nursing and assisted living operations. The majority of the revenue is generated from the skilled services segment.
<h3>Ensign Group: Delving into Financials</h3>
Revenue Growth: Over the 3 months period, Ensign Group showcased positive performance, achieving a revenue growth rate of 14.99% as of 30 September, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Health Care sector.
Holistic Profitability Examination:
<ul>
<li>
Gross Margin: The company issues a cost efficiency warning with a low gross margin of 15.44%, indicating potential difficulties in maintaining profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): Ensign Group's EPS is below the industry average. The company faced challenges with a current EPS of 1.38. This suggests a potential decline in earnings.
</li>
</ul>
Debt Management: Ensign Group's debt-to-equity ratio is below the industry average. With a ratio of 1.15, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
Financial Valuation Breakdown:
<ul>
<li>
Price to Earnings (P/E) Ratio: A higher-than-average P/E ratio of 24.63 suggests caution, as the stock may be overvalued in the eyes of investors.
</li>
<li>
Price to Sales (P/S) Ratio: With a relatively high Price to Sales ratio of 1.72 as compared to the industry average, the stock might be considered overvalued based on sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): Ensign Group's EV/EBITDA ratio, surpassing industry averages at 18.17, positions it with an above-average valuation in the market.
</li>
</ul>
Market Capitalization: Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Why Insider Transactions Are Key in Investment Decisions</h3>
Insider transactions shouldn't be used primarily to make an investing decision, however an insider transaction can be an important factor in the investing decision. 
When discussing legal matters, the term "insider" refers to any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, as stipulated in Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and significant hedge funds. Such insiders are required to report their transactions through a Form 4 filing, which must be completed within two business days of the transaction.
A new purchase by a company insider is a indication that they anticipate the stock will rise.
On the other hand, insider sells may not necessarily indicate a bearish view and can be motivated by various factors.
<h3>Breaking Down the Significance of Transaction Codes</h3>
Digging into the details of stock transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> frequently turn their attention to those taking place in the open market, as outlined in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001125376">Check Out The Full List Of Ensign Group's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;utm_source=benzinga-insights">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Major Purchase Alert: Christopher Christensen Invests $649K In Ensign Group Stock

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Canaccord Genuity cut Illumina, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ILMN#NASDAQ">ILMN</a>) price target from $145 to $135. Canaccord Genuity analyst Kyle Mikson maintained a Hold rating. Illumina shares closed at $122.80 on Thursday. <a href="https://www.benzinga.com/quote/ILLMN/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Stephens &amp; Co. raised the price target for The Ensign Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENSG#NASDAQ">ENSG</a>) from $155 to $160. Stephens &amp; Co. analyst Raj Kumar maintained an Overweight rating. Ensign shares closed at $135.91 on Thursday. <a href="https://www.benzinga.com/quote/ENSG/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Cantor Fitzgerald boosted Cloudflare, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NET#NYSE">NET</a>) price target from $111 to $149. Cantor Fitzgerald analyst Thomas Blakey maintained a Neutral rating. Cloudflare shares closed at $141.52 on Thursday. <a href="https://www.benzinga.com/quote/NET/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Benchmark cut the price target for Weatherford International plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WFRD#NASDAQ">WFRD</a>) from $140 to $125. Benchmark analyst Kurt Hallead maintained a Buy rating. Weatherford International shares closed at $65.36 on Thursday. <a href="https://www.benzinga.com/quote/WFRD/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Goldman Sachs raised the price target for Yum! Brands, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YUM#NYSE">YUM</a>) from $140 to $155. Goldman Sachs analyst Christine Cho maintained a Neutral rating. Yum! Brands shares closed at $144.01 on Thursday. <a href="https://www.benzinga.com/quote/YUM/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Scotiabank slashed Qualys, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QLYS#NASDAQ">QLYS</a>) price target from $150 to $140. Scotiabank analyst Patrick Colville maintained a Sector Perform rating. Qualys shares settled at $140.71 on Thursday. <a href="https://www.benzinga.com/quote/QLYS/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Oppenheimer raised Expedia Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXPE#NASDAQ">EXPE</a>) price target from $210 to $235. Oppenheimer analyst Jed Kelly maintained an Outperform rating. Expedia shares closed at $172.57 on Thursday. <a href="https://www.benzinga.com/quote/EXPE/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Raymond James raised Take-Two Interactive Software, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTWO#NASDAQ">TTWO</a>) price target from $190 to $220. Raymond James analyst Andrew Marok reiterated an Outperform rating. Take-Two shares closed at $183.08 on Thursday.  <a href="https://www.benzinga.com/quote/TTWO/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Tigress Financial raised the price target for Royal Caribbean Cruises Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RCL#NYSE">RCL</a>) from $270 to $330. Tigress Financial analyst Ivan Feinseth maintained a Buy rating. Royal Caribbean Cruises shares settled at $270.20 on Thursday. <a href="https://www.benzinga.com/quote/RCL/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Rosenblatt raised Amazon.com, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) price target from $236 to $287. Rosenblatt analyst Barton Crockett maintained a Buy rating. Amazon shares closed at $238.83 on Thursday. <a href="https://www.benzinga.com/quote/AMZN/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/02/43558786/how-to-earn-500-a-month-from-mcdonalds-stock-ahead-of-q4-earnings">How To Earn $500 A Month From McDonald&#8217;s Stock Ahead Of Q4 Earnings</a></li>
</ul>

Markets

AMZN

EXPE

ILMN

QLYS

TTWO

WFRD

Amazon To Rally Over 20%? Here Are 10 Top Analyst Forecasts For Friday

Stephens &amp; Co. analyst Raj Kumar maintains Ensign Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENSG#NASDAQ">ENSG</a>) with a Overweight and raises the price target from $155 to $160.

Stephens & Co. Maintains Overweight on Ensign Group, Raises Price Target to $160

Providing a diverse range of perspectives from bullish to bearish, 4 analysts have published ratings on Ensign Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENSG#NASDAQ">ENSG</a>) in the last three months.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $162.75, a high estimate of $175.00, and a low estimate of $155.00. This current average has decreased by 0.36% from the previous average price target of $163.33. 
<img src="https://www.benzinga.com/files/images/story/2025/1738868434_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
A clear picture of Ensign Group's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Raj Kumar</td>
<td>Stephens &amp; Co.</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$155.00</td>
<td>$155.00</td>
</tr>
<tr>
<td>Tao Qiu</td>
<td>Macquarie</td>
<td>Raises</td>
<td>Outperform</td>
<td>$166.00</td>
<td>$165.00</td>
</tr>
<tr>
<td>David Macdonald</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Hold</td>
<td>$155.00</td>
<td>$170.00</td>
</tr>
<tr>
<td>A.J. Rice</td>
<td>UBS</td>
<td>Announces</td>
<td>Buy</td>
<td>$175.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Ensign Group. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Ensign Group compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Ensign Group's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Ensign Group's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/ENSG/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Ensign Group analyst ratings.</a>
<h2>Unveiling the Story Behind Ensign Group</h2>
Ensign Group Inc provides post-acute healthcare services in the United States. Its regional subsidiaries oversee skilled nursing, assisted living, home health and hospice, mobile ancillary, and urgent care operations. Medicare and Medicaid programs contribute a majority of revenue received for Ensign's services. The firm operates through two segments, Skilled services, and Standard Bearer. The skilled services segment includes the operation of skilled nursing facilities and rehabilitation therapy services. The Standard Bearer segment comprises of properties owned by the company through its captive REIT and leased to skilled nursing and assisted living operations. The majority of the revenue is generated from the skilled services segment.
<h3>Key Indicators: Ensign Group's Financial Health</h3>
Market Capitalization Analysis: The company's market capitalization is above the industry average, indicating that it is relatively larger in size compared to peers. This may suggest a higher level of investor confidence and market recognition.
Revenue Growth: Ensign Group's revenue growth over a period of 3 months has been noteworthy. As of 30 September, 2024, the company achieved a revenue growth rate of approximately 14.99%. This indicates a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Health Care sector.
Net Margin: Ensign Group's net margin excels beyond industry benchmarks, reaching 7.25%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Ensign Group's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 4.61% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Ensign Group's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.73% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: Ensign Group's debt-to-equity ratio is below the industry average. With a ratio of 1.15, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>Analyst Ratings: Simplified</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

4 Analysts Assess Ensign Group: What You Need To Know

Ensign Group shares are trading lower. The company reported Q4 financial results.

Stephens &amp; Co. analyst Raj Kumar reiterates Ensign Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENSG#NASDAQ">ENSG</a>) with a Overweight and maintains $155 price target.

Reiteration

Stephens & Co. Reiterates Overweight on Ensign Group, Maintains $155 Price Target

Ensign Group Sees FY25 EPS $6.16-$6.34 Vs $6.16 Est.; Revenue $4.83B-$4.91B Vs $4.771B Est.

Ensign Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENSG#NASDAQ">ENSG</a>) reported quarterly earnings of $1.49 per share which beat the analyst consensus estimate of $1.48 by 0.68 percent. This is a 16.41 percent increase over earnings of $1.28 per share from the same period last year. The company reported quarterly sales of $1.132 billion which beat the analyst consensus estimate of $1.129 billion by 0.27 percent. This is a 15.47 percent increase over sales of $980.378 million the same period last year.

Ensign Group Q4 2024 Adj. EPS $1.49 Beats $1.48 Estimate, Sales $1.132B Beat $1.129B Estimate

ALGN

AMSC

AOSL

APPS

ARAY

ARES

ASGN

ASYS

AZTA

BARK

BLBD

BSBR

CENT

CENTA

CMRE

CNMD

CNXN

COHR

CPAY

CPRI

CRTO

CSGS

CTSH

CTVA

DGII

DLHC

EQNR

EZPW

FORM

GEOS

HOLX

ITUB

KMPR

LFVN

LSAK

LUCK

LVWR

MSTR

MTRX

MUSA

NOTV

NTGR

NVST

NWSA

ODFL

ORLY

PAHC

PFGC

Earnings Scheduled For February 5, 2025

Press Releases

The Ensign Group to Present at the 35th Annual Oppenheimer Healthcare MedTech & Services Conference on March 18, 2025

UPDATE – The Ensign Group to Present at the 35th Annual Oppenheimer Healthcare MedTech & Services Conference on March 18, 2025

Dividends

The Ensign Group, Inc. Declares Quarterly Dividend of $0.0625 Per Share

General

The Ensign Group Adds Two Operations in California

The Ensign Group Expands in California

The Ensign Group Purchases Two Facilities in Washington

CareTrust REIT Announces $55 Million Acquisition of Two California Facilities in Separate Transactions

The Ensign Group Schedules First Quarter Earnings Call for Wednesday, April 30, 2025

The Ensign Group Reports First Quarter 2025 Results; Raises Annual Earnings and Revenue Guidance

Comments

Ensign Group

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL